A Part of the University of Maryland Medical Center

Connect with UMGCC
Facebook Twitter YouTube Blog iPhone
Email PageEmail page Print PagePrint page

Research Programs

Frontiers in Oncology Seminars

2011 - 2012 Frontiers in Oncology Seminars

The Frontiers in Oncology lecture series brings outstanding investigators involved in cancer research to the UMGCC campus each month. The series is designed to educate and provide exposure to the latest developments in cancer biology, treatment and diagnosis. It will be of interest to faculty members, oncologists, medical interns, nurses, pharmacologists, and research fellows.

When: 3rd Wednesday of every month, 8:00 a.m.

University of Maryland Health Science Facility II (HSF II) Auditorium
20 S. Penn Street, Baltimore, MD 21201

CME Credit: One (1)
Register online.

Note: If you would like to meet with the speaker, please contact Florence Wade.

2011-2012 Seminar Schedule
Dr. Kevin Cullen, Dr. Jeffrey Toretsky, Dr. Edward Sausville (sponsor), Dr. Dhan Kalvakolanu

September 21, 2011

Jeffrey A. Toretsky, M.D.
Vincent T. Lombardi Cancer Research Center
Georgetown University Medical Center
Washington, DC

Disordered Proteins Cause Challenges, But Open Opportunities When Targeting Tumorigenic Transcription

Dr. Tyler J. Curiel, Dr. Ginette Serrero (sponsor) and Dr. Kevin Cullen

October 19, 2011

Tyler Curiel, M.D., M.P.H.
Professor of Medicine
University of Texas Health Science Center
Immunology and Infectious Disease
San Antonio, TX 78229

Developing Rational Multi-modal Approaches to Managing Regulatory T Cells as Novel Cancer Immunotherapy

Dr. Kevin Cullen, Dr. Janet Rowley, and Dr. Feyruz Rassool (sponsor)

November 16, 2011

Janet Rowley, M.D.
Professor of Medicine
Department of Hematology and Oncology
University of Chicago Medical Center
Chicago, IL 60637

The Philadelphia Story

December 21, 2011 -- CANCELLED

Carlos L. Arteaga, M.D.
Professor of Medicine and Cancer Biology
Interim Director, Division of Hematology/Oncology
Director, Breast Cancer Program
Vanderbilt-Ingram Cancer Center
Nashville, TN 37232-6307


Dr. Arnob Banerjee (sponsor); Dr. Robert H. Vonderheide; Dr. Curt Civin; Dr. Dhan Kalvakolanu

January 18, 2012

Robert Vonderheide, M.D., D.Phil.
Associate Professor
Department of Medicine, Hematology and Oncology
University of Pennsylvania School of Medicine
Philadelphia, PA 19104

Immunobiology and Immunotherapy of Pancreatic Cancer in Mice and Humans

Dr. Xian-Fan Wang (speaker) and Dr. Dhan Kalvakolanu

February 15, 2012

Xiao-Fan Wang, Ph.D.
Professor of Pharmacology and Cancer Biology
Duke University Medical Center
Durham, NC 27710

Tumor Microenvironment: The Roles of microRNAs and Tumor Metastasis

Dr. John Kyriakis and Dr. Dhan Kalvakolanu

March 21, 2012

John M. Kyriakis, Ph.D.
Professor of Medicine
Tuffs University School of Medicine
Boston, MA 02111

New Functions for the Mst2 Tumor Suppressor Protein

Dr. Michael F. Clarke, Dr. Ginette Serrero, Dr. Dhan Kalvakolanu and Dr. Curt Civin

April 11, 2012

Michael F. Clarke, M.D.
Professor of Medicine and Oncology
Deputy Director, Stanford Institute for Stem Cell Biology and Regenerative Medicine
Stanford University School of Medicine
Stanford, CA 94305

Dysregulation of Self-Renewal Pathways in Cancer

Dr. Kevin Cullen; Dr. Theodore Lawrence and Dr. Curt Civin

May 16, 2012

Theodore S. Lawrence, M.D., Ph.D.
Professor, Department of Radiation Oncology
Isadore Lampe Chair Radiation Oncology
University of Michigan
Ann Arbor, MI 48109

Combining Targeted Therapies with Chemoradiation

June 20, 2012 -- CANCELLED

Lisa M. Coussens, Ph.D.
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, CA 94143-0502


This page was last updated on: August 27, 2013.